QMSR Guide
QMSR Harmonization: How FDA Aligned Part 820 With ISO 13485
On February 2, 2026, FDA's Quality System Regulation gave way to the Quality Management System Regulation, which adopts ISO 13485:2016 by reference. This guide explains why FDA harmonized, what it kept for itself, where the familiar QSR records went, and how the old sections map onto the standard.
At a Glance
- Rule
- Quality Management System Regulation (QMSR)
- Published
- February 2, 2024 (89 FR 7496)
- In effect
- February 2, 2026
- Incorporates
- ISO 13485:2016; ISO 9000:2015, Clause 3
- Replaces
- Quality System Regulation (1996)
- Full regulation page
- 21 CFR Part 820 (QMSR)
A plain-language guide based on the final rule and the current regulation text, not legal advice. Always read the current official text.
Why FDA Harmonized With ISO 13485
For almost 30 years, US device makers followed FDA's Quality System Regulation (QSR), last revised in 1996, while much of the rest of the world used ISO 13485. With each revision the two grew closer, and FDA's final rule notes that the 2016 edition of ISO 13485 is substantially similar to the QSR. Companies selling in more than one market were maintaining two overlapping systems, auditing against both and training staff on both.
FDA's experience in the Medical Device Single Audit Program (MDSAP) settled the question. When FDA compared ISO 13485 with the QSR to decide what the US needed on top of the standard for MDSAP audits, it found very few FDA-specific requirements were missing. In the final rule, FDA concluded that ISO 13485 provides a comprehensive and effective approach to a medical device quality management system.
So FDA replaced the QSR's own requirement text with ISO 13485:2016, incorporated by reference, and kept a short list of FDA-specific provisions on top. FDA published the final rule on February 2, 2024, and it took effect on February 2, 2026. FDA's stated goals are less duplicated effort, internal audits and management reviews run against one aligned set of requirements, simpler training, and faster patient access to safe and effective devices.
What Changed, and What Stayed FDA-Specific
ISO 13485:2016 Is Now the Rulebook
Section 820.10 requires a documented quality management system that complies with the applicable requirements of ISO 13485:2016 and the rest of Part 820. The QSR's former sections 820.20 through 820.250 are gone. Terms are read through ISO 13485 and Clause 3 of ISO 9000:2015, which Part 820 also incorporates for definitions.
FDA Definitions Still Win
Under 820.3, the definitions in the Federal Food, Drug, and Cosmetic Act override the standard's, so device and labeling keep their US meaning. "Organization" means manufacturer, and "safety and performance" means safety and effectiveness. FDA also keeps its own definitions of component, finished device, batch or lot, rework, remanufacturer and implantable device.
Design Controls Follow Device Class, as Before
Under 820.10(c), Clause 7.3 on design and development applies to class II and class III devices and to the same short list of class I devices: devices automated with software, plus five listed device types such as surgeon's gloves and tracheobronchial suction catheters.
Other FDA Rules Are Wired Into Specific Clauses
Section 820.10(b) links ISO 13485 clauses to other FDA regulations: Clause 7.5.8 identification to UDI under Part 830, Clause 7.5.9.1 traceability to device tracking under Part 821, Clause 8.2.3 reporting to Medical Device Reporting under Part 803, and advisory notices under Clauses 7.2.3, 8.2.3 and 8.3.3 to corrections and removals under Part 806.
Two Supplemental Provisions Add Detail
Section 820.35 adds required content for complaint records, servicing records and UDI on top of Clause 4.2.5. Section 820.45 adds labeling and packaging controls on top of Clause 7.5.1: examination for accuracy before release, documented release, and controls to prevent mix-ups.
Risk Management Runs Through Everything
The QSR named risk analysis mainly under design validation (former 820.30(g)). FDA's final rule points out that ISO 13485 builds risk-based decisions into Clauses 4.1, 7.1, 7.3, 7.4, 7.5, 7.6 and 8.2, so risk management now has to show up across the quality system, not only in the design file.
Where the DMR, DHF and DHR Went
ISO 13485 has no device master record, design history file or device history record. FDA retired those terms and explained where their content now lives.
| Under the QSR | Under the QMSR | What FDA says |
|---|---|---|
| Device master record (DMR) | Medical device file (Clause 4.2.3) | FDA says specifications and manufacturing, measuring, monitoring, servicing and installation procedures that lived in the DMR now belong in the medical device file. |
| Design history file (DHF) | Design and development file (Clause 7.3.10) | Contains or references the records that show design and development requirements were met, including the plan and procedures. |
| Device history record (DHR) | Record for each device or batch (Clause 7.5.1) | FDA notes that what the DHR held is largely required in the device or batch record. |
| Quality system record (QSR) | Documentation under Clause 4.2 | No separate record type. FDA eliminated the term along with DMR, DHF and DHR. |
| Establish | Document | Per Clause 0.2 of ISO 13485, "document" includes establishing, implementing and maintaining. FDA dropped its separate definition of establish. |
| Corrective action | Correction and corrective action | FDA added "correction" in 820.35(a)(6) to match Clause 8.2.2. |
Records FDA Can Now Read
Under the QSR, section 820.180(c) shielded management review, internal quality audit and supplier audit reports from FDA inspection. The QMSR has no such exception. FDA rejected requests to keep it, explaining that regulators in other countries and MDSAP auditing organizations already see these records, so keeping the exception would work against harmonization.
FDA also stated that it does not consider producing these records a large burden, since they are kept in the normal course of business, and that strong management review and audit programs are central to the culture of quality it expects. For many companies these reports were written for an internal audience. They are now evidence, and it is worth reading them the way an investigator would.
QSR to ISO 13485 Crosswalk
Where each former QSR section's ground is now covered. The regulation itself has no crosswalk table: this is our mapping by subject, to orient a transition. Confirm details against ISO 13485:2016 and the current Part 820 text.
| Former QSR section | ISO 13485:2016 clause | FDA addition under the QMSR |
|---|---|---|
| 820.20 Management responsibility | 5 Management responsibility (5.1 to 5.6) | None beyond the standard |
| 820.22 Quality audit | 8.2.4 Internal audit | Reports now open to inspection |
| 820.25 Personnel | 6.2 Human resources | None beyond the standard |
| 820.30 Design controls | 7.3 Design and development | 820.10(c) sets which devices |
| 820.30(j) Design history file | 7.3.10 Design and development files | None beyond the standard |
| 820.40 Document controls | 4.2.4 Control of documents | None beyond the standard |
| 820.50 Purchasing controls | 7.4 Purchasing | Supplier audit reports now open to inspection |
| 820.60 Identification | 7.5.8 Identification | 820.10(b)(1): UDI under Part 830 |
| 820.65 Traceability | 7.5.9 Traceability | 820.10(b)(2) and (d): Part 821; 7.5.9.2 for life-supporting devices |
| 820.70 Production and process controls | 7.5.1 Control of production; 6.3 Infrastructure; 6.4 Work environment | None beyond the standard |
| 820.72 Inspection, measuring and test equipment | 7.6 Control of monitoring and measuring equipment | None beyond the standard |
| 820.75 Process validation | 7.5.6 Validation of processes; 7.5.7 Sterilization and sterile barrier systems | None beyond the standard |
| 820.80 and 820.86 Acceptance activities and status | 8.2.6 Monitoring and measurement of product; 7.5.8 Identification | None beyond the standard |
| 820.90 Nonconforming product | 8.3 Control of nonconforming product | None beyond the standard |
| 820.100 Corrective and preventive action | 8.5.2 Corrective action; 8.5.3 Preventive action | None beyond the standard |
| 820.120 and 820.130 Labeling and packaging | 7.5.1 Control of production | 820.45 labeling and packaging controls |
| 820.140 and 820.150 Handling and storage | 7.5.11 Preservation of product | None beyond the standard |
| 820.170 Installation | 7.5.3 Installation activities | None beyond the standard |
| 820.180 Records, general requirements | 4.2.5 Control of records | 820.35; the 820.180(c) exception is gone |
| 820.181 Device master record | 4.2.3 Medical device file | None beyond the standard |
| 820.184 Device history record | 7.5.1 Record for each device or batch | None beyond the standard |
| 820.198 Complaint files | 8.2.2 Complaint handling; 8.2.3 Reporting to regulatory authorities | 820.35(a) record content; Part 803 |
| 820.200 Servicing | 7.5.4 Servicing activities | 820.35(b) record content |
| 820.250 Statistical techniques | 8.1 General; 8.4 Analysis of data | None beyond the standard |
Questions About QMSR Harmonization
Does an ISO 13485 certificate mean we comply with the QMSR?
Not by itself. The QMSR is ISO 13485:2016 plus FDA's own definitions, the clause links to UDI, tracking, MDR and corrections and removals, and the supplemental record and labeling requirements in 820.35 and 820.45. A certified system is a strong start, but FDA inspects against Part 820, and a standard ISO 13485 certification audit does not assess the FDA-specific provisions. MDSAP audits do include FDA's requirements.
Do we have to rename our DMR, DHF and DHR?
The QMSR does not require particular file names. What it requires is that the content ISO 13485 calls for exists and can be found: the medical device file, the design and development file, and the record for each device or batch. Many companies keep their familiar names and add a mapping in the quality manual so an investigator can follow it.
Which edition of ISO 13485 applies?
Section 820.7 incorporates ISO 13485:2016, the third edition, and Clause 3 of ISO 9000:2015 for definitions. A later edition would not apply in the US until FDA amends Part 820 to incorporate it.
Were there changes after the final rule?
FDA published technical amendments to the QMSR in the Federal Register on December 4, 2025 (90 FR 55978). Always check the current text in the eCFR rather than a copy saved during the transition.
Sources
Primary Sources
- Federal Register: Quality System Regulation Amendments, final rule, 89 FR 7496 (February 2, 2024) (opens in a new tab)
- eCFR: 21 CFR Part 820, Quality Management System Regulation (opens in a new tab)
- Federal Register: QMSR technical amendments, 90 FR 55978 (December 4, 2025) (opens in a new tab)
- FDA: Quality Management System Regulation (QMSR) (opens in a new tab)
QMSR Transition
Find the Gaps Between Your System and the QMSR
An AI-assisted first pass maps your existing procedures and records against ISO 13485:2016 and the FDA-specific provisions, and an advisor reviews every result. Please don't send confidential documents yet: secure upload is set up after onboarding.


